Over recent years newspapers have been reporting on overweight Sri Lankans. The news is that about 33% of Sri Lankan adults ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...

If you are looking to lose weight sustainably for long-term results you must take your gut health into consideration Get more ...

Excessive weight has been a persistent problem in America, where at least one in five adults in each U.S. state is living ...

Pediatric growth hormone deficiency (GHD) is a relatively rare condition, affecting an estimated 1 in 4,000-10,000 children.

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize ...

The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...

This article reviews the potential clinical uses of antagonists of growth-hormone-releasing hormone (GHRH) for tumor therapy. GHRH antagonists suppress the growth of various human cancer lines ...

OPKO Health strengthens finances by selling BioReference and focusing on drug development. Click here to read an analysis of ...

As a patriotic layperson, I feel compelled to bring to the attention of the nation and our policymakers a critical discussion ...

Novo Nordisk has reported new data with its long-acting human growth hormone (hGH) product Sogroya, showing it is at least as effective as its older drug Norditropin in various paediatric growth ...